Lv21
140 积分 2023-12-06 加入
Linvoseltamab, a BCMA-directed CD3 T-cell engager for multiple myeloma: a patient-centric option via a response-adapted dosing regimen
59分钟前
已完结
Population Pharmacokinetics of Tarlatamab, a Half-Life Extended DLL3-Directed Bispecific T-Cell Engager in Patients with Previously Treated Small Cell Lung Cancer
25天前
已完结
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
26天前
已完结
FIH dose selection beyond MABEL: Optimizing phase 1 clinical trial starting dose whilst protecting patient safety
2个月前
已完结
Strategies and Recommendations for Using a Data‐Driven and Risk‐Based Approach in the Selection of First‐in‐Human Starting Dose: An International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Assessment
2个月前
已完结
Relation of Lifespan to Brain Weight and Body Weight in Mammals
3个月前
已完结
Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development☆☆☆
3个月前
已完结
Selective Targeting of STAT6: Recent Advances and Future Perspectives
3个月前
已完结
Dupilumab demonstrates improvements in biomarker levels across racial subgroups in pediatric patients with moderate-to-severe atopic dermatitis
3个月前
已完结
Pharmacokinetic Drug-Drug Interactions with Drugs Approved by the US Food and Drug Administration in 2020: Mechanistic Understanding and Clinical Recommendations
3个月前
已完结
皖公网安备34019202002308
